Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare
Cartesian Therapeutics Inc. Revenue 2014–2025
Cartesian Therapeutics Inc. annual/quarterly revenue history and growth rate from 2014 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cartesian Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Cartesian Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 400000, a 99.12% decrease year-over-year.
- Cartesian Therapeutics Inc. annual revenue for 2025 was 400000, a 98.95% decrease from 2024.
- Cartesian Therapeutics Inc. annual revenue for 2024 was 38.3 M, a 47.19% increase from 2023.
- Cartesian Therapeutics Inc. annual revenue for 2023 was 26.0 M, a 76.53% decrease from 2022.
- Cartesian Therapeutics Inc. annual revenue for 2022 was 110.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cartesian Therapeutics Inc. Earnings — FAQ
Cartesian Therapeutics Inc. (RNAC) earnings over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RNAC's earnings history?
The chart and table above show Cartesian Therapeutics Inc.'s earnings by year and by quarter, including the growth rate.